Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 24, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $52.67B | $398.70 | -2.21% | $151.92M | 1,286.13x | 19.74 | United States | 45 |
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | A | $34.60B | $312.32 | -0.33% | $318.03M | 6,246.40x | 0.85 | Cayman Islands | 53 |
| FIX | COMFORT SYSTEMS USA INC | NYSE | Engineering & Construction | A | $34.05B | $965.37 | 1.53% | $1.21B | 40.78x | 1.59 | United States | 61 |
| NVT | NVENT ELECTRIC PLC | NYSE | Electrical Equipment & Parts | A | $16.78B | $103.97 | 1.15% | $1.08B | 28.33x | 0.86 | United Kingdom | 42 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.68B | $147.28 | -0.17% | $679.20M | 34.17x | 0.42 | United States | 55 |
| VTRS | VIATRIS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.84B | $12.02 | 0.08% | -$598.90M | -3.89x | 1.49 | United States | 30 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.30B | $169.47 | -0.12% | $182.64M | -28.29x | 1.87 | Ireland | 16 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $6.05B | $11.97 | -0.91% | N/A | 24.04x | 0.60 | Guernsey | 35 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.73B | $22.19 | 0.77% | $672.10M | 24.12x | 1.02 | United States | 37 |
| CPA | COPA HOLDINGS SA | NYSE | Airlines | A | $5.02B | $121.95 | -1.43% | $1.12B | 8.38x | 1.42 | Panama | 41 |
| UGP | ULTRAPAR HOLDINGS INC | NYSE | Oil & Gas Refining & Marketing | A | $4.03B | $3.72 | 2.48% | $1.18B | 10.08x | N/A | Brazil | 31 |
| CALX | CALIX INC | NYSE | Software - Application | A | $3.67B | $55.43 | -0.82% | $10.21M | -554.30x | 0.19 | United States | 28 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.62B | $22.47 | -0.71% | $339.10M | 13.54x | 4.64 | Bermuda | 30 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.54B | $195.95 | 1.06% | $301.16M | 11.35x | 1.82 | United States | 52 |
| EXTR | EXTREME NETWORKS INC | NASDAQ | Communication Equipment | A | $2.24B | $16.77 | -1.29% | $65.83M | 239.57x | 15.82 | United States | 34 |
| ANIP | ANI PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $1.81B | $80.73 | 0.01% | $165.21M | 47.21x | 1.78 | United States | 50 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.65B | $51.98 | -0.74% | $194.43M | 12.96x | 1.45 | United States | 52 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.59B | $7.53 | -1.05% | $83.87M | -150.60x | -2.15 | United States | 17 |
| DNOW | DNOW INC | NYSE | Oil & Gas Equipment & Services | A | $1.43B | $13.62 | 0.67% | $165.00M | 15.30x | 0.40 | United States | 42 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $1.39B | $50.04 | -0.58% | -$82.14M | -18.26x | -13.00 | United States | 15 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.23B | $46.37 | 0.24% | $119.00M | 41.77x | 0.93 | United States | 38 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.20B | $4.16 | 1.22% | $137.29M | 52.00x | 0.68 | United States | 41 |
| NUTX | NUTEX HEALTH INC | NASDAQ | Health Information Services | A | $1.18B | $167.34 | -6.80% | $227.40M | 7.89x | 1.66 | United States | 54 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.07B | $20.39 | 3.71% | $219.28M | 6.54x | 0.79 | France | 51 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $940.99M | $18.57 | -1.28% | $55.37M | 32.02x | 0.79 | Cayman Islands | 37 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $729.74M | $5.75 | 0.70% | $18.04M | -47.92x | 0.49 | United States | 20 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $515.71M | $13.82 | -1.85% | $145.14M | N/A | 6.80 | Mexico | 45 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $502.90M | $12.06 | -2.19% | -$1.00M | -7.09x | 1.31 | United States | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $434.44M | $14.22 | -1.25% | $86.84M | 38.43x | 2.69 | United States | 32 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $273.12M | $1.97 | -4.37% | $51.06M | -49.25x | 4.04 | United States | 12 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $237.48M | $12.74 | -4.14% | $11.65M | N/A | 0.39 | United States | 26 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $228.11M | $27.35 | -1.69% | $12.05M | 28.20x | 0.20 | United States | 54 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $226.31M | $5.75 | 3.23% | -$5.00M | -22.12x | 0.61 | United States | 17 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $202.82M | $6.60 | -1.05% | $7.94M | 44.00x | 0.24 | United States | 44 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $183.84M | $9.04 | -1.31% | $24.16M | 34.77x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.